Evidence map›Paper›PMID 30337127›Full record

ArticleJournal of hepatology2019

Individual surveillance using model-based hepatocellular carcinoma risk estimates in chronic hepatitis C patients after antiviral treatment.

Fanpu Ji, Yee Hui Yeo, Caini He, Jie Li, Xuesong Gao, Zongfang Li, Linda Henry, Mindie H Nguyen

Abstract readLetterComment
PubMed Publisher
In one paragraph

Article in Journal of hepatology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Fanpu JiDepartment of Infectious Disease, the Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China; Shaanxi Provincial Clinical Research Center for Hepatic & Splenic Diseases, the Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China. Electronic address: infection@xjtu.edu.cn.
Yee Hui YeoDivision of Gastroenterology and Hepatology, Stanford University Medical Center, Palo Alto, CA, United States.
Caini HeDepartment of Infectious Disease, the Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Jie LiDepartment of Infectious Disease, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, Shandong, China; Shandong Provincial Engineering and Technological Research Center for Liver Diseases Prevention And Control, Jinan, Shandong, China.
Xuesong GaoDepartment of General Medicine, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
Zongfang LiShaanxi Provincial Clinical Research Center for Hepatic & Splenic Diseases, the Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China; National & Local Joint Engineering Research Center of Biodiagnosis and Biotherapy, the Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Linda HenryDivision of Gastroenterology and Hepatology, Stanford University Medical Center, Palo Alto, CA, United States.
Mindie H NguyenDivision of Gastroenterology and Hepatology, Stanford University Medical Center, Palo Alto, CA, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antiviral AgentsCarcinoma, HepatocellularHepatitis CHepatitis C, ChronicLiver NeoplasmsHumansAntiviral Agents

Identifiers

PMID30337127

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.